EUCROF: Essentials of Paediatric Research
Healixia: Session Pharmacovigilance
GA4GH 8th Plenary Meeting
The 8th Plenary will bring together organizations and stakeholders from the genomics and health community for two days of keynotes, talks, updates, and workshops that will focus on advancing development work for the immediate data sharing needs of the community.
Vereniging Innovatieve Geneesmiddelen: Coronaproof, medicijnen en vaccins – lessons learned
Vaccinology Masterclass
In het programma van de tweedaagse van dit jaar komen verschillende aspecten van het vaccineren aan bod met een focus op het belang van de mucosale afweer, de mogelijk ongewenste effecten van vaccineren, toepassing van vaccins voor ontwikkelingslanden en de ontwikkeling van nieuwe vaccins voor respiratoire virussen. Uiteraard is er ook uitgebreid aandacht voor de laatste ontwikkelingen en inzichten omtrent COVID-19.
NVFG Jaarcongres 2020
ZonMw: Masterclass jongerenparticipatie in onderzoek – oktober
Op vrijdag 2 oktober 2020 organiseert ZonMw in samenwerking met Christine Dedding (Amsterdam UMC) opnieuw de Masterclass Jongerenparticipatie in onderzoek. Zowel onderzoekers in het jeugdveld als jongeren die interesse hebben om hun stem te laten horen in onderzoek zijn van harte welkom. De masterclass is bedoeld voor onderzoekers die graag meer jongeren willen betrekken bij onderzoek, voor onderzoekers die enige ervaring hebben met het betrekken van jongeren en voor jongeren zelf. Na afloop ben je aan het denken gezet over de vragen: wat is participatie, waarom is het zo belangrijk, is het altijd nodig en wanneer is het goed genoeg?
EFIB 2020 Digital
Event on Industrial Biotechnology and the Bioeconomy.
ENRIO: First Congress on Research Integrity Practice
The ENRIO2020 Congress is aimed for research integrity officers, research directors, science funding organisations, research networks, and other professionals in the field of research integrity and research ethics, members of ethics committees, and university teachers and researchers.
Cambridge Innovation Institute: Bio-IT World Conference & Expo:
Bio-IT World unites an ecosystem of over 3,000 leading life sciences, pharmaceutical, clinical, healthcare, informatics and technology experts in the field of biomedical research, drug discovery & development, and healthcare from around the world. With this united community, Bio-IT World is the place to explore the future of precision medicine and the technologies that are powering it.
CDISC: 2020 US Interchange
DARQA: webinar ‘Remote site audits’
Als gevolg van het rondwarende Coronavirus is het zo goed als onmogelijk geworden om nog on-site audits uit te voeren zoals GCP (Good Clinical Practice) voorschrijft. Dat betekent dat er andere manieren om die audits – op afstand – uit te voeren gevonden moeten worden. Daarbij moet rekening worden gehouden met andere wet- en regelgeving en moet gebruik worden gemaakt van andere audit technieken en nieuwe technologiën. Een veranderde mindset bij zowel de auditee als de auditor zijn ook onontbeerlijk. In deze brainstormsessie gaan we, onder beleiding van een aantal ervaren GCP-auditors, bespreken welke mogelijkheden en onmogelijkheden er zijn wat betreft het uitvoeren van audits op afstand in de USA, Europa en in de rest van de wereld. Uiteraard is er tijdens de webinar voldoende gelegenheid om vragen te stellen en/of je eigen ervaringen te delen.
EFGCP & DIA: Better Medicines for Children Conference
This year, in 2020, 13 years after the EU Paediatric Regulation came into force, our aim is to build on achievements and lessons learnt so far and to look at the future of paediatric drug development, with a specific focus on putting patients at the heart of innovation and regulatory science.
Pistoia Alliance: Lab of the Future Europe Congress
The Lab of the Future Congress is an exciting, large scale, multidisciplinary conference and exhibition allowing participants to discuss and debate best practice with industry peers and solution providers. Located within the Wellcome Genome Campus in Cambridge UK, the Lab of the Future Congress offers an opportunity for an open and flexible congress format in the heart of a world class research hub. The event aims to drive the successful incorporation of new technologies and thinking into the lab to enable collaboration, foster innovation and deliver new medicines.
Patient Engagement Open Forum 2020: Parallel sessions
PARADIGM, PFMD and EUPATI welcome you to the Patient Engagement Open forum – a series of virtual events where we will work together, in a multi-stakeholder context, to turn patient engagement into reality.
National Survey on Research Integrity (NSRI) Launch Symposium
Held both in Amsterdam and online by livestream, this symposium explores the concept of research integrity and why the NSRI initiative is the beginning of a journey towards better research practice for all. The symposium serves as a kick-off for the NSRI launch and all are welcome. This meeting is open to all disciplines of researchers interested in research integrity and relevant stakeholders who contribute to the scientific system. The meeting will be announced online and through the social media channels of collaborating endorsers of the NSRI when relevant. The event will be held in English so as to enable researchers of all backgrounds to join. The set-up is aimed at stimulating a lively, interactive exchange and dialogue among speakers and attendees. Participants can join onsite or online depending on Covid-19 circumstance.
BeCRO: 10th anniversary event ‘CRO vs. Biotech/Pharma battle’
Pistoia Alliance Annual USA Conference 2020
Technology is driving change in life sciences R&D and Healthcare. The Pistoia Alliance 2020 Annual USA Conference will offer a unique opportunity for its members to come together to discuss important developments across the pharma and life science R&D value chain.
Healixia: CTR Session
Joint MEB/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing Training Course
The 5 days of training include a comprehensive overview of the core processes and systems in place and the latest news on the international harmonisation and standardisation activities in pharmacovigilance. Now available in individual Modules.
WCG Centerwatch: FDAnews/CenterWatch Virtual Conference – Part III — The Real-World Costs of Data Integrity
Patient Engagement Open Forum 2020: Parallel sessions
PARADIGM, PFMD and EUPATI welcome you to the Patient Engagement Open forum – a series of virtual events where we will work together, in a multi-stakeholder context, to turn patient engagement into reality.
ELIXIR: BioHackathon Europe
BioHackathon activities are driven by practical sessions where people gather, discuss, and implement ideas/projects during intensive and productive coding sessions. The topics will be aligned to challenges proposed by ELIXIR platforms (data, tools, compute, interoperability and training), ELIXIR communities (Human Data, Rare Diseases, Marine Metagenomics, Plant Science, Metabolomics and Proteomics), and a set of common challenges proposed by the sister BioHackathon organised in Japan.
Healixia: Workshop: Pioneering malaria challenge trials in Belgium: from theory to practice in a Phase I unit
Human Challenge Trials (HCT) or Human Infection Models (HIM) are an extremely effective way of validating treatment efficacy using real-world symptomology studies. The challenge of infectious agents with vaccine (or drug) in vivo offers early access to mode of action (MOA) and proof of concept (POC) data prior to designing later, larger phase field trials. The last two decades have seen a surge in antimalarial drug development with product development partnerships taking a leading role. The development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead. New drugs are needed, particularly those with new mechanisms of action. Malaria Volunteer Infection Studies (VIS) serve as a valuable tool in antimalarial drug development. Both for prophylactic and curative treatment, models have been developed in clinical trials by injection of infected red blood cells or direct inoculation with malaria sporozoites. Pioneer trials have already been performed in different countries such as Australia and the Netherlands. Last year, the first malaria-VIS trial has been performed in Belgium, aiming to investigate a prophylactic treatment. A second VIS-trial testing a curative treatment model will start in March 2020. This workshop offers unique insights about Belgium’s pioneer malaria-VIS trials from the scientific community, the sponsor’s and the investigator’s perspective.
RQA International QA Conference ’20/20 Vision: A New Frontier?’
Join us for a varied programme with a focus on our conference theme ’20/20 Vision: A New Frontier?’ from the comfort of your desk. As usual we will be running plenary sessions, GxP streams, QA Clinics and more. We will have a large, free exhibition area for anyone who wishes to attend, a poster display and a range of virtual networking tools, such as 1:1 chat, chatrooms, discussions and a community lounge.
DARQA Themadag GMP: Vaccinontwikkeling
Aan het programma van deze dag wordt nog gewerkt maar duidelijk is al dat er weer goede sprekers uit het werkveld zullen zijn en zoals altijd zal er voldoende tijd zijn voor netwerken in een vertrouwelijke en informele sfeer. Afhankelijk van de omstandigheden met betrekking tot het coronavirus en de daarbij behorende maatregelen kan het zijn dat deze bijeenkomst virtueel zal plaatsvinden.
Oncode: Clinical workshop Melanoma
Healixia: Annual conference
BBMRI-ERIC & ESBB: Europe Biobank Week conference: “Biobanking for Global Challenges!”
RSNN & EMA: Leveraging the value of collaboration – from regulatory science to regulatory innovation
One of the main goals of regulatory science is to inform decision-making with the best evidence, and contribute to a regulatory system that is responsive to societal needs, ensures patient access to efficacious and safe medicines, adapts to scientific innovation and conducive to a fertile R&D ecosystem. In this RSNN workshop we want to explore the key regulatory science questions in the coming years, and especially address how collaborative research can be of most value for regulators, patients, companies, HTA bodies, academia and other stakeholders. Discussions with the audience, representing various backgrounds are a critical element in this respect.
EUCROF: Medical Device Regulation Clinical Evidence – Benefit & Risk Evaluation
Patient Engagement Open Forum 2020: conclusion session
PARADIGM, PFMD and EUPATI welcome you to the Patient Engagement Open forum – a series of virtual events where we will work together, in a multi-stakeholder context, to turn patient engagement into reality.
HollandBIO: Guiding Cancer Treatments in the 21st Century
Healixia: Session Medical Devices
6e Jaarcongres Gezondheidsrecht
Voor het 6e Jaarcongres Gezondheidsrecht is een gevarieerd programma samengesteld van terugkerende en nieuwe onderwerpen. Wat kunt u verwachten:
> Nieuwe coronavirussen: driemaal is scheepsrecht
> Eén jaar ervaring met de Wvggz en Wzd vanuit verschillende perspectieven belicht
> De nieuwe Verordening medische hulpmiddelen (MDR) en de implementatie ervan in Nederland
> Highlights tuchtrechtspraak
> Goed bestuur en toezicht in de zorg: actualiteiten
> Ontwikkelingen medische aansprakelijkheid
> Actualiteiten zorgbekostiging, zorginkoop & gevolgen Covid-19
> Transitie van de zorg: de juiste zorg op de juiste plek anno 2020!
> Terugblikken op Covid-19
> Actualiteiten zorgbekostiging en zorgcontractering
> De Wet medisch wetenschappelijk onderzoek
> Actualiteiten strafrecht in de zorg
> Privacy en gegevensuitwisseling
Dit jaarcongres wordt georganiseerd door GZR Updates Gezondheidsrecht in samenwerking met Studiecentrum Kerckebosch.
EUCROF – Clinical trials with ATMP’s
National Open Science Festival
The National Open Science Festival provides researchers the opportunity to learn about the benefits of various Open Science practices. It is a place to meet peers that are already working openly or that are interested to start doing so. Key to this day is sharing knowledge and best practices. However, you don’t need to have extensive knowledge of Open Science to attend; there will also be sessions for those who simply want to know more about the different aspects of Open Science, its drivers and its barriers.